Government Mulls Bringing Cancer, AIDS Drugs Under Price Control

Published: 29th May 2014 04:57 PM  |   Last Updated: 29th May 2014 04:57 PM   |  A+A-


NEW DELHI: Drug prices regulator NPPA is looking at bringing medicines used for treating diseases such as cancer, AIDS and malaria under the price control mechanism.

The National Pharmaceutical Pricing Authority met recently to consider ways of bringing medicines, which are not covered by the list of essential drugs, under some regulatory ambit in order to check prices, sources said.

"We are examining the possible actions to bring down the prices in public interest in case of drugs whose prices vary to a great extent and the treatment is very costly," a senior official said.

The prices of some of the medicines targeting diseases like cancer vary up to 600 per cent, the official added.

"Moreover, NPPA is also examining the prices of medicines targeting malaria and dysentery," the official said.

As of May last year, prices of 348 medicines in the National List of Essential Medicines were under control with the implementation of Drug Prices Control Order (DPCO), 2013.

The move followed the approval of National Pharmaceutical Pricing Policy (NPPP) 2012 by the Cabinet on November 22, 2012. This was later notified on December 7, 2012.

The NPPA has been authorised to fix and revise prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country.

It is also mandated to monitor the prices of decontrolled drugs in order to keep them at reasonable levels.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp